CALSTART to Defend EPA's Clean Truck Standards in Court
Legal Motion in Support of Standards Critical to Clean Transportation
In response to the motion to intervene filed today, CALSTART's President and CEO,
"Our intervention is a continuation of our strong and unwavering support for standards that are mission-critical for the clean transportation industry. We have been vocal in our support for the science-based rulemaking process at each phase—and today is no exception.
With these standards under attack, we are compelled to defend them. Critically, these phased-in standards provide the regulatory certainty that the industry depends on for long-term infrastructure planning and investments. Without strong market signals, our clean transportation momentum would be stymied, and we would forfeit enormous health and climate benefits for people and planet.
The EPA standards are a step in the right direction to get us on a path toward 100 percent new zero-emission medium- and heavy-duty vehicle (MHDV) sales by 2040, a goal enshrined in an international agreement among 36 countries, including the
Our overall message to the court is simple: there is no turning back now—not when these standards are what will help propel the transportation sector forward and not when
Background:
At the time of writing, the heavy-duty vehicles standards are being challenged by 25 Republican-led states.
To learn more about the significance of the EPA's Clean Truck Standards, please see CALSTART's press release in response to EPA's announcement earlier this year.
About CALSTART
A mission-driven industry organization focused on transportation decarbonization and clean air for all, CALSTART has offices in New
View original content to download multimedia:https://www.prnewswire.com/news-releases/calstart-to-defend-epas-clean-truck-standards-in-court-302172680.html
SOURCE CALSTART Inc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boliden's mining concession for Laver maintained as appeals rejected
- Senhwa's CX-5461 Opens a New Frontier in Photoimmunotherapy; Multinational Study Published in Nucleic Acids Research
- MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share